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periods, glycogen may have a role in the development of 
hypoglycemia unawareness.
Keywords Glycogen · Brain · Hypoglycemia 
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Introduction
Episodes of hypoglycemia are a major complication of gly-
cemia control by insulin administration. Diminished brain 
function during a hypoglycemia episode leads to poten-
tial physical danger and may have long-lasting damaging 
effects on the brain, resulting in cognitive impairment [1]. 
Moreover, recurrent hypoglycemia also impairs the body’s 
defence mechanisms against hypoglycemia. Many patients 
with diabetes display a progressive decay in the counter-
regulatory response over time, resulting in reduction of 
hypoglycemia awareness [2], where the glycemia threshold 
for counter-regulation is shifted to lower plasma glucose 
levels and may be detected only upon severe neuroglyco-
penia [3].
The precise mechanisms that sense blood glucose and 
link the sensory machinery to the autonomic and endocrine 
responses which alert the patient to the low blood glucose 
levels and ultimately restore glucose homeostasis are not 
completely understood [4]. Much less is known about the 
mechanisms responsible for hypoglycemia unawareness, 
where a drop in glycemia is only detected when neuro-
glycopenia occurs [3]. It has been proposed that recurrent 
hypoglycemia leads to increased fuel availability to the 
brain, either glucose [5–7] or monocarboxylates [8] that 
are readily available from circulation. In addition, glyco-
gen “supercompensation” may play a role in hypoglycemia 
unawareness, in which the brain adapts to hypoglycemia by 
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increasing glucose storage in the form of extra glycogen 
content [9, 10].
Brain glycogen is hydrolysed to support energy metabo-
lism and aid preserving neuronal function during hypo-
glycaemia [9–15]. Evidence supporting this post-hypogly-
cemia supercompensation has been reported in the human 
[12, 16], rat [9, 14], mouse [10] and rainbow trout [15]. 
However, the re-establishment of glycogen content in the 
brain after hypoglycaemia has been involved in contro-
versy: (1) not all studies confirmed glycogen supercom-
pensation after acute hypoglycaemia [11], (2) there have 
been reports suggesting that repeated hypoglycaemia does 
not result in increased glycogen levels [11, 16, 17], and 
(3) patients with type 1 diabetes and hypoglycaemia una-
wareness display brain glycogen levels similar to those in 
healthy subjects [18].
The aim of the present study was to test the hypothesis 
that brain glycogen concentrations are replenished above 
the normal levels after a hypoglycemia insult and to what 
extent this supercompensation is related to post-hypoglyce-
mia glucose levels.
Methods
Animals
All procedures were performed in accordance to the Swiss 
animal welfare legislation under approval of the local eth-
ics committee (EXPANIM-SCAV). Male Sprague-Dawley 
rats (238 ± 8  g, n = 22, from Charles River, France) were 
housed on a 12-h light–dark cycle, room temperature 
at 22 °C, humidity at 60%, and with Food (Kliba Nafag 
3800, Provimi-Kliba, Kaiseraugst, Switzerland) and water 
ad libitum.
Intra‑venous Catheter Implantation
Micro-renathane catheters (inner/outer diameter in mm: 
0.635/1.016; Braintree Scientific, Braintree, MA USA) 
were washed with 70% ethanol and soaked in saline with 
200 U/mL heparin (Liquemin, Drossapharm, Basel, Swit-
zerland) for 2  h. After fasting for 6  h, rats were anesthe-
tized with 2% isoflurane (Attane, Minrad, NY, USA) in 
30% oxygen in air. Surgery was performed under aseptic 
conditions. Core temperature was maintained at 37 °C. 
Areas in the right shoulder at the base of the neck and in 
the nape of the neck were shaved and thoroughly cleaned 
with 70% ethanol prior to skin incision. The right exter-
nal jugular vein was isolated and a heparinised catheter 
was inserted and advanced to reach the vena cava. After 
secured to the vein with threads, the catheter was then tun-
nelled under the skin and exteriorised through the incision 
in the nape of the neck. Skin incisions were closed, catheter 
was filled with heparin solution (200 U/mL in saline) and 
rats were allowed to recover in a cage with water ad  libi-
tum. Food was provided on the following day. The cath-
eter was flushed daily with saline and refilled with heparin 
solution under short isoflurane anesthesia. For three days, 
rats received 50  mg/kg intramuscular amoxicillin (Clam-
oxyl, Pfizer, Zurich, Switzerland) and 50 μg/kg subcutane-
ous buprenorphine (Temgesic, ESSEX Chemie, Luzern, 
Switzerland).
Hypoglycemia and Recovery
On the fifth day after surgery at 9:00 in the morning, 2 h 
after the beginning of the light cycle, rats were briefly anes-
thetised under isoflurane, and the implanted catheter was 
flushed and connected to an infusion line running through 
a swivel mounted in a counterbalanced lever arm (Instech, 
Plymouth Meeting, PA, USA). The rat was allowed to wake 
up in the cage with free access to water, and saline infusion 
started. The implanted catheter was also used for repeated 
blood sampling. When glucose was present in the infusate, 
infusion was interrupted and catheters were flushed before 
sampling, thus preventing contamination of blood samples 
with glucose from the infusate. In some cases, glycemia 
was confirmed by cross-measuring a drop of blood from 
the tail tip with the Ascencia Contour glucometer (Bayer, 
Zürich, Switzerland). Plasma glucose and lactate concen-
trations were quantified by the glucose and lactate oxidase 
methods, respectively, using GM7 Micro-Stat analysers 
(Analox Instruments, London, UK). Insulin (Huminsulin, 
Eli Lilly, Switzerland) was given as a bolus of 1 U/kg and 
continuous infusion at 6  U/kg/h aiming at a target hypo-
glycemia of 2  mmol/L for 90  min. Simultaneous glucose 
infusion at 50 µmol/h (using a 5 mmol/L solution) allowed 
controlling the degree of hypoglycemia. Insulin was only 
administered to rats submitted to hypoglycemia. Recovery 
from hypoglycemia was achieved by infusing glucose (5 
or 20% in saline) with variable rate aiming at maintaining 
stable plasma glucose for 24 h. The 12-h light–dark cycle 
was not interrupted. Control rats were submitted to either 
normo- or hyperglycemia for 24  h without a precedent 
hypoglycemia period. The following experimental groups 
were studied: control (n = 6), hypoglycemia for 90  min 
(n = 3), normoglycemia followed by hyperglycemia (n = 4), 
and hypoglycemia followed by either normoglycemia 
(n = 4) or hyperglycemia (n = 5).
Glycogen Quantification
Rats were sacrificed using a focused microwave fixa-
tion device (Gerling Applied Engineering, Modesto, CA, 
USA) at 4 kW and 2450 MHz for 2 s under short isoflurane 
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anaesthesia [19]. Small tissue samples (10–25  mg) from 
occipital cortex, hippocampus, striatum and hypothalamus 
were dissected, frozen in liquid  N2 and stored at −80 °C. 
Samples were homogenised in 30  mmol/L HCl with an 
ultrasonic homogenizer Sonopuls HD 2070 with the micro-
tip MS 73 (Bandelin, Berlin, Germany) and, together with 
glycogen standards (concentrations from 2  µmol/L to 
200 mmol/L; glycogen from oyster Type II, Sigma-Aldrich, 
Basel, Switzerland), were boiled for 45 min at 90 °C. After 
adjusting pH to 5 with sodium acetate, samples and stand-
ards were incubated in the presence or absence of 20 ng/mL 
amylo-α-1,4-α-1,6-glucosidase (Roche Applied Science, 
Rotkreuz, Switzerland) for 2  h at 37 °C [19]. After enzy-
matic digestion, pH was adjusted to 7. After centrifuga-
tion at 14,000×g for 15  min, supernatants were collected 
for glucose determination. Glucose concentration was 
determined by the glucose oxidase method coupled to a 
peroxidase reaction [20]. Briefly, samples, glycogen stand-
ards and freshly prepared glucose standards (concentrations 
from 1 µmol/L to 2 mmol/L) were diluted in sodium phos-
phate buffer (50 mmol/L, pH 7.4) and incubated in 96 wells 
microplates with 2 U/mL glucose oxidase (Sigma-Aldrich), 
0.2  U/mL horseradish peroxidase (Sigma-Aldrich) and 
100  μmol/L AmplexRed (Invitrogen, Basel, Switzerland) 
for 30 min in the dark. The product of AmplexRed oxida-
tion, resorufin, was detected at 560 nm with a PowerWave 
XS microplate spectrophotometer (BioTek, Luzern, Swit-
zerland). From the glycogen standards submitted to the 
same extraction protocol as the tissue homogenates, calcu-
lated recovery was always above 96%. Glycogen concentra-
tion was reported in terms of glucosyl equivalents released 
after amylo-α-1,4-α-1,6-glucosidase digestion, and normal-
ised to tissue’s wet weight.
Statistical Analysis
Data are shown as mean ± SEM, and were analysed with 
ANOVA followed by Bonferroni multiple comparison tests, 
using Prism 5.04 (GraphPad, San Diego, CA, USA). Sig-
nificance was considered for P < 0.05.
Results
To allow infusion and blood sample collection in freely-
moving conscious rats at low blood pressure under severe 
hypoglycemia, a permanent catheter was placed into the 
superior vena cava. Good recovery from surgery was indi-
cated by absence of weight loss within 5 days of recovery 
(238 ± 8 g prior to surgery vs. 246 ± 9 g 5 days later).
Insulin was infused to achieve hypoglycaemia, which 
was maintained at 2  mmol/L or below during 99 ± 6  min 
(n = 12, Fig.  1). After hypoglycemia, rats were infused 
with glucose solutions to achieve normo- and hyperglyce-
mia clamps for 24 h, resulting in mean plasma glucose of 
9.5 ± 1.3  mmol/L (n = 4) and 18.2 ± 1.5  mmol/L (n = 5), 
respectively. The animals subjected to the 24-h hypergly-
cemia clamp without preceding hypoglycaemia had mean 
plasma glucose of 18.9 ± 2.2 mmol/L (n = 4). Plasma levels 
of lactate followed glycemia variations (Fig. 1). Brain glu-
cose concentration was reduced by hypoglycemia (P < 0.05 
for all regions), and increased in accordance to plasma 
glucose levels (Fig.  2a). The relation of brain glucose to 
plasma glucose, which depends on both glucose uptake and 
the cerebral metabolic rate of glucose  (CMRglc) was similar 
among the experimental groups (Fig. 2b).
Fig. 1  Plasma glucose and 
lactate levels during insulin-
induced hypoglycemia and 
recovery by glucose infusion. 
Data are shown as mean ± SEM. 
Experimental groups: control 
(Ctrl, black circles, n = 6), 
hypoglycemia (Hypo, white 
squares, n = 3), normoglycemia 
followed by hyperglycemia 
(Normo+Hyper, white circles, 
n = 4), and hypoglycemia fol-
lowed by either normoglycemia 
(Hypo+Normo, white trian-
gles, n = 4) or hyperglycemia 
(Hypo+Hyper, black triangles, 
n = 5)
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Glycogen concentrations in control rats were simi-
lar to those reported elsewhere [19–21], suggesting that 
the surgery as well as the infusion protocol did not affect 
brain glycogen metabolism. In control rats, the glyco-
gen concentration was 3.6 ± 0.1, 4.7 ± 0.3, 2.8 ± 0.2 and 
4.7 ± 0.5  μmol/g in cortex, hippocampus, striatum and 
hypothalamus, respectively (Fig.  3), in line with known 
regional glycogen distribution [22].
Insulin-induced hypoglycemia reduced glycogen levels 
in the four brain regions (P < 0.05, n = 3, Fig. 3). Namely, 
glycogen reduction ranged between −87 ± 7% in the hip-
pocampus (P < 0.001, n = 3) and −84 ± 3% in the cortex 
(P < 0.01, n = 3), compared to controls. During this period 
of hypoglycemia, glycogenolysis was estimated to be 0.03, 
0.04, 0.02, 0.04  μmol/g/min in the cortex, hippocampus, 
striatum and hypothalamus, respectively, in agreement with 
previous reports [9]. A 24-h period of recovery caused a 
reversion of hypoglycemia-induced glycogen depletion in 
the cortex, hippocampus and striatum (Fig. 3). After 24 h 
of recovery under normoglycemia, rats displayed glycogen 
content increase in the cortex (116 ± 12%, P < 0.001, n = 4), 
hippocampus (86 ± 31%, P < 0.001, n = 4) and striatum 
(96 ± 37%, P < 0.05, n = 4), relative to controls. Recovery 
under hyperglycemia caused brain glycogen to rise above 
Fig. 2  Brain glucose concentration at the time of tissue collection 
(a), and its relation to plasma glucose levels (b). The grey line in 
panel B depicts the relation of brain  (Gbrain) to plasma  (Gplasma) glu-
cose at steady-state in the rat brain under light α-chloralose anesthesia 
reported previously [30]. Data are shown as mean ± SEM of n = 3–6, 
and were analysed with two-way ANOVA followed by Bonferroni 
post-tests. Glycemia challenges impacted brain glucose concentra-
tion (F = 48.5, P < 0.0001). Brain areas show similar glucose levels 
(F = 0.74, P > 0.05), and interaction was not significant between the 
two variables (F = 1.2, P > 0.05). Post-test comparison to control: 
*P < 0.05. Experimental groups: control (Ctrl, black circles, n = 6), 
hypoglycemia (Hypo, white squares, n = 3), normoglycemia followed 
by hyperglycemia (Normo+Hyper, white circles, n = 4), and hypogly-
cemia followed by either normoglycemia (Hypo+Normo, white trian-
gles, n = 4) or hyperglycemia (Hypo+Hyper, black triangles, n = 5)
Fig. 3  Brain glycogen concentration (in glucosyl units) was 
increased after 24 h of recovery from 90 min of hypoglycemia in the 
cortex, hippocampus and striatum but not hypothalamus. Data are 
shown as mean ± SEM of n = 3–6, and were analysed with two-way 
ANOVA followed by Bonferroni post-tests. Both glycemia challenges 
and regional distribution were source of variation for glycogen con-
centration with F-values of 47.3 (P < 0.0001) and 8.0 (P < 0.001), 
respectively. Interaction was not significant between the two vari-
ables (F = 1.8, P > 0.05). Post-test comparison to control: *P < 0.05, 
**P < 0.01, ***P < 0.001. Experimental groups: control (Ctrl, n = 6), 
hypoglycemia (Hypo, n = 3), normoglycemia followed by hyper-
glycemia (Normo+Hyper, n = 4), and hypoglycemia followed by 
either normoglycemia (Hypo+Normo, n = 4) or hyperglycemia 
(Hypo+Hyper, n = 5)
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controls by 65 ± 26% (P < 0.01, n = 5), 52 ± 16% (P < 0.01, 
n = 5) and 80 ± 18% (P < 0.05, n = 5) in the cortex, hip-
pocampus and striatum, respectively. In the hypothala-
mus, glycogen concentration recovered to baseline, i.e. not 
higher to that of controls, independently of blood glucose 
levels after the hypoglycemia episode. The hyperglycemia 
clamp without preceding hypoglycaemia was devoid of 
effects on brain glycogen (Fig. 3).
Discussion
The present study shows that excessive glycogen stor-
age occurs in the rat brain after a severe hypoglycemia 
insult and is independent of the blood glucose levels dur-
ing recovery. Notably, glycogen supercompensation upon 
24-h recovery following hypoglycemia was observed 
in the hippocampus, cortex and striatum, but not in the 
hypothalamus.
Brain glycogen supercompensation after episodes of 
hypoglycemia have been matter of debate [9–12, 16–18, 
23], probably due to distinct experimental approaches, 
hypoglycemia severity and animal models used. Using 
13C magnetic resonance spectroscopy in rats to meas-
ure brain glycogen upon labelling from [1-13C]glucose, 
Choi et  al. reported a 153% increase in the amount of 
13C-labeled glycogen after 7-h hyperglycemia recovery 
from insulin-induced acute hypoglycemia of 2  mmol/L 
for 2  h, when compared to the concentration measured 
before hypoglycemia [9]. In mice, after 6-h of euglyce-
mic recovery from insulin-induced acute hypoglycemia 
there was a 25% increase in whole brain glycogen con-
tent, relative to that measured in controls [10]. How-
ever, 27  h after the hypoglycemia period, brain glyco-
gen levels approached baseline levels. Furthermore, the 
authors [10] observed similar results when animals had 
been previously submitted to daily recurrent hypoglyce-
mia insults for 9 days. Resembling the effect of systemic 
hypoglycemia, neuroglycopenia induced by repetitive 
intracerebroventricular injection of 2-deoxy-d-glucose 
for 3  days induced increases in brain glycogen content 
in the hypothalamus and cortex by 69 and 153%, respec-
tively, in comparison to saline-injected rats [23]. In 
contrast to these reports, Herzog et  al. [11] did not find 
glycogen supercompensation after either acute or recur-
rent hypoglycemia in the rat cortex, cerebellum or and 
hypothalamus. Moreover, brain glycogen turnover in rats 
recovering from chronic hypoglycemia (<3  mmol/L for 
12–14  days) was similar to controls [17]. Oz et  al. [18] 
used 13C magnetic resonance spectroscopy in conjunction 
with [1-13C]glucose administration measure brain glyco-
gen content and metabolism in patients with type 1 dia-
betes and hypoglycemia unawareness, as well as healthy 
volunteers. This study also did not support the hypothesis 
that post-hypoglycemia glycogen supercompensation is 
the driver for hypoglycaemia unawareness [18], although 
a single hypoglycaemia episode was shown to elicit gly-
cogen supercompensation in healthy subjects [12, 16]. 
Nevertheless, increased brain glucose storage could be 
favoured by increased glucose uptake after hypoglycae-
mia. Indeed, it has been proposed that recurrent hypogly-
cemia leads to a sustained increase in brain glucose [5–7, 
17] due to enhanced expression and density of glucose 
carriers [24, 25].
Brain glycogen supercompensation was also observed 
in rats after depletion upon exhaustive exercise [26]. While 
brain glycogen levels decreased with exercise, they were 
supercompensated at 6  h after exercise in several brain 
areas, including the cortex, hippocampus and hypothala-
mus [26]. The authors further observed that brain glycogen 
supercompensation after exercise positively correlated with 
the decrease rate during exercise and that it was sustained 
until 24  h after exercise in both cortex and hippocampus 
(long-lasting supercompensation) but not in the hypothal-
amus, a brain area involved in maintenance of peripheral 
glucose homeostasis. In analogy to the present study, one 
may speculate that overshot of glycogen content may also 
occur in the hypothalamus after a few hours of recovery 
from hypoglycemia but at 24  h they had already normal-
ised. Accordingly, repetitive neuroglucopenia in three con-
secutive days induced much larger glycogen supercompen-
sation in cortex than hypothalamus [23]. Increased glial 
glycogen stores can eventually sustain neuronal activity 
for a longer period [13] during a subsequent hypoglycemia 
episode and, therefore, contribute to the shift in the glyce-
mia threshold at which counter-regulation initiates. How-
ever, it remains to be addressed whether excessive content 
of glycogen can effectively buffer brain glucose supply to 
glucose-sensing neurons for longer periods.
In our study, glycogenolysis during hypoglycaemia was 
estimated to range between 0.02 and 0.04  µmol/g/min 
across the four measured regions, which is a small contri-
bution to the brain’s energy requirements. Relative to the 
respective regional  CMRglc in awake rats [27, 28], we esti-
mated that glycogenolysis only accounted to about 2% in 
the striatum, 3% in the cortex, 5% in the hippocampus, and 
7% in the hypothalamus. However, blood-to-brain glucose 
transport becomes limiting for hexokinase at hypoglycae-
mia, resulting in reduced  CMRglc [29, 30]. Therefore, with 
a 50% reduction in  CMRglc during hypoglycemia [29], gly-
cogenolysis may represent up to 30% of glucose utilisa-
tion. In addition, oxidation of endogenous substrates such 
as amino acids can also contribute to fuel the brain during 
hypoglycaemia, and their normal concentration is readily 
re-established upon recovery [31, 32], at a rate much faster 
than the replenishment of brain glycogen stores [31].
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Although this study was not designed to investigate glu-
cose transport and consumption rates, we compared brain 
versus plasma glucose levels with the expected values 
that we derived from a previous study [30] (Fig. 2b). Care 
should be taken when comparing these datasets because 
arterial plasma glucose was measured in our previous study 
[30], and we now measured glucose in venous plasma col-
lected from the vena cava. Since venous plasma has lower 
glucose levels than arterial plasma, one should expect 
a displacement of the present data from the line plotted 
in Fig. 2b towards larger brain to plasma glucose. On the 
other hand, awake rats have larger  CMRglc and thus lower 
brain glucose levels at the same glycemia, when compared 
to anesthetised rats (in previous study [30]). In spite of 
that, such differences between the two datasets are likely 
not detectable by this approach. It is interesting to note that 
the relation between brain and plasma glucose, which is 
dependent on glucose uptake and  CMRglc, in rats submit-
ted to hypoglycemia and subsequent recovery for 24  h is 
not substantially different from that previously reported at 
steady-state in control rats under light α-chloralose anes-
thesia [30]. In other words, we did not observe impor-
tant deviations of measured brain glucose levels from the 
expected values at a given plasma glucose. Acute hypogly-
cemia of 2 mmol/L was reported to cause a 40–50% reduc-
tion of  CMRglc in the four regions analysed in our study 
[29]. More severe hypoglycemia episodes (blood glucose 
of 1–1.5  mmol/L) result in further reduction of  CMRglc 
by nearly 75% [32]. However,  CMRglc is rapidly normal-
ised upon recovery (within 10 min in the absence of hypo-
glycemic coma) [32]. On the other hand,  CMRglc is not 
expected to change upon acute hyperglycemia [33]. While 
it has been proposed that recurrent hypoglycemia leads to 
increased glucose transport from plasma to brain [5–7], 
the present results suggest that a single hypoglycemia epi-
sode does not alter the brain-to-blood glucose relationship. 
Therefore, assuming similar  CMRglc for all experimental 
groups, glucose transport across the blood–brain-barrier 
does not appear contributing to augment brain glycogen 
storage after hypoglycemia.
All together, these results suggest that glycogen content 
and metabolism may have a role in diabetic hypoglycemia 
unawareness, even though very little is known on brain gly-
cogen metabolism in diabetes. While animal models of dia-
betes show unaltered glucose transport at the blood–brain-
barrier (see [34] and references therein), thus leading to 
high brain glucose concentration at hyperglycemia, they 
do not display evident alteration of brain glycogen levels 
(reviewed in [35]). Similarly, patients with insulin-depend-
ent diabetes and hypoglycemia unawareness display normal 
brain glycogen concentration [18]. Contrastingly, increased 
glycogen concentration was reported in the brain of obese, 
insulin resistant Zucker diabetic fatty rats [36].
Insulin modulates brain function and was reported to act 
on brain glycogen [19, 37]. Insulin and insulin-like growth 
factor I (IGF-I) have been implicated in the regulation of 
glycogen synthesis in cultured astrocytes [37]. We also 
previously found that the administration of somatostatin 
to supress systemic insulin release, while infusing glu-
cose, resulted in decreased glycogen content in the rat brain 
[19]. A limitation of this study is that control rats were 
not administered exogenous insulin. While an experimen-
tal group with insulin infusion and normoglycemic clamp 
was not included, the 24-h hyperglycemic clamp is known 
to result in hyperinsulinemia. Therefore, it is likely that all 
animal groups, including those not challenged with hypo-
glycaemia, had high circulating insulin levels. Moreover, 
brain glycogen supercompensation after exhaustive exer-
cise was reported to be unrelated to blood insulin levels 
[26].
We conclude that brain glycogen concentrations are 
replenished above their normal levels after a single hypo-
glycemic insult independently of the post-hypoglycemia 
glucose levels. The effects of severity and duration of the 
hypoglycemia insult on the degree of glycogen supercom-
pensation remain to be ascertained.
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